PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.13%
Net income growth above 1.5x TSM's 4.46%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-0.48%
Negative yoy D&A while TSM is 1.94%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
100.00%
Lower deferred tax growth vs. TSM's 240.68%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-100.00%
Negative yoy SBC while TSM is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-17952.38%
Both reduce yoy usage, with TSM at -222.74%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-100.00%
AR is negative yoy while TSM is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-12.31%
Both reduce yoy inventory, with TSM at -129.56%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
100.00%
AP growth of 100.00% while TSM is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-7148.17%
Both reduce yoy usage, with TSM at -162.26%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
526.92%
Well above TSM's 91.72%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-47.14%
Both yoy CFO lines are negative, with TSM at -1.32%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-116.12%
Both yoy lines negative, with TSM at -89.71%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-36.15%
Both yoy lines negative, with TSM at -22.70%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-22.96%
We reduce yoy sales while TSM is 60.92%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-1107.50%
Both yoy lines negative, with TSM at -24.87%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while TSM is 51.29%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-3.25%
We cut yoy buybacks while TSM is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.